Table 1 Pathway enrichments
From: Detecting recurrent gene mutation in interaction network context using multi-scale graph diffusion
KEGG pathways | Pik3-cluster | Runx-cluster | ||
|---|---|---|---|---|
| Â | Rank | p-value | Rank | p-value |
Cell cycle | 60 | 0.11 | 1 | 1.7E-10 |
Prostate cancer | 4 | 1.4E-07 | 2 | 1.3E-08 |
Chronic myeloid leukemia | 2 | 4.1E-10 | 3 | 3.6E-08 |
Pathways in cancer | 8 | 3.4E-07 | 4 | 9.2E-08 |
HTLV-I infection | 28 | 0.001 | 5 | 5.2E-07 |
Small cell lung cancer | 20 | 4.6E-05 | 6 | 8.9E-07 |
Colorectal cancer | 14 | 2.1E-06 | 7 | 8.3E-06 |
Glioma | 3 | 3.1E-08 | 8 | 5.2E-05 |
p53 signaling pathway | 73 | 0.27 | 9 | 5.3E-05 |
Transcriptional misregulation in cancer | 77 | 0.36 | 10 | 5.3E-05 |
T cell receptor signaling pathway | 1 | 1.1E-11 | 35 | 0.47 |
B cell receptor signaling pathway | 5 | 1.5E-07 | 34 | 0.44 |
Non-small cell lung cancer | 6 | 1.6E-07 | 13 | 0.0002 |
Fc epsilon RI signaling pathway | 7 | 3.2E-07 | 65 | 0.95 |
ErbB signaling pathway | 9 | 7.9E-07 | 21 | 0.05 |
Pancreatic cancer | 10 | 8.7E-07 | 14 | 0.0003 |